Assembly Biosciences Statistics
Total Valuation
ASMB has a market cap or net worth of $107.81 million. The enterprise value is $338,081.
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ASMB has 6.35 million shares outstanding. The number of shares has increased by 24.66% in one year.
| Shares Outstanding | 6.35M |
| Shares Change (YoY) | +24.66% |
| Shares Change (QoQ) | +2.91% |
| Owned by Insiders (%) | 12.17% |
| Owned by Institutions (%) | 11.20% |
| Float | 3.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.12 |
| Forward PS | 7.00 |
| PB Ratio | 3.11 |
| P/FCF Ratio | 4.47 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.01 |
Financial Position
The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.74 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.07 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -101.78% and return on invested capital (ROIC) is -67.81%.
| Return on Equity (ROE) | -101.78% |
| Return on Assets (ROA) | -34.72% |
| Return on Capital (ROIC) | -67.81% |
| Revenue Per Employee | $330,477 |
| Profits Per Employee | -$701,708 |
| Employee Count | 65 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASMB has paid $439,000 in taxes.
| Income Tax | 439,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.47% in the last 52 weeks. The beta is 0.65, so ASMB's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +54.47% |
| 50-Day Moving Average | 14.60 |
| 200-Day Moving Average | 12.81 |
| Relative Strength Index (RSI) | 64.39 |
| Average Volume (20 Days) | 15,479 |
Short Selling Information
The latest short interest is 10,283, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 10,283 |
| Short Previous Month | 12,335 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
In the last 12 months, ASMB had revenue of $21.48 million and -$45.61 million in losses. Loss per share was -$8.76.
| Revenue | 21.48M |
| Gross Profit | -28.49M |
| Operating Income | -50.53M |
| Pretax Income | -45.17M |
| Net Income | -45.61M |
| EBITDA | -50.27M |
| EBIT | -50.53M |
| Loss Per Share | -$8.76 |
Full Income StatementBalance Sheet
The company has $109.22 million in cash and $1.75 million in debt, giving a net cash position of $107.47 million or $16.94 per share.
| Cash & Cash Equivalents | 109.22M |
| Total Debt | 1.75M |
| Net Cash | 107.47M |
| Net Cash Per Share | $16.94 |
| Equity (Book Value) | 34.68M |
| Book Value Per Share | 5.47 |
| Working Capital | 71.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $24.33 million and capital expenditures -$235,000, giving a free cash flow of $24.10 million.
| Operating Cash Flow | 24.33M |
| Capital Expenditures | -235,000 |
| Free Cash Flow | 24.10M |
| FCF Per Share | $3.80 |
Full Cash Flow StatementMargins
Gross margin is -132.61%, with operating and profit margins of -235.24% and -212.33%.
| Gross Margin | -132.61% |
| Operating Margin | -235.24% |
| Pretax Margin | -210.29% |
| Profit Margin | -212.33% |
| EBITDA Margin | -234.01% |
| EBIT Margin | -235.24% |
| FCF Margin | n/a |